Connect with us

The Plunge Daily

After Serum Institute, Bharat Biotech also reduces its vaccine price for states

Bharat Biotech's Covaxin gets DCGI nod for phase 2,3 trial for 2-18 age group


After Serum Institute, Bharat Biotech also reduces its vaccine price for states

A day after Serum Institute of India, Hyderabad-based Bharat Biotech has also slashed the price of its Covaxin from ₹ 600 to ₹ 400 per dose for state governments. Earlier, the company had kept the price at ₹600 for one dose. There is no change in the price of Covaxin for private markets and it remains at ₹1,200 per dose.

“Recognising the enormous challenges to the public healthcare system, we have made Covaxin available to state governments at a price of Rs 400 per dose,” the company said in its statement.

“We wish to be transparent in our approach to pricing which was determined by internally funded product development, several operationally-intensive BSL-3 manufacturing facilities, and clinical trial,” it added.

On Wednesday, SII also announced it plans to reduce price of its Covishield vaccine for states from Rs 400 to Rs 300 per dose.

“As a philanthropic gesture on behalf of Serum Institute of India, I hereby reduce the price to the states from Rs 400 to Rs.300 per dose, effective immediately; this will save thousands of crores of state funds going forward. This will enable more vaccinations and save countless lives,” Poonawalla wrote in his tweet.

On April 25, Bharat Biotech had announced Covaxin’s price at ₹600 per dose for state governments and ₹1,200 for private hospitals. Recently, Covaxin has been found to neutralise the 617 variant of the deadly virus, according to America’s top pandemic expert Dr Anthony Fauci.

Also Read: 

COVID-19 vaccine: Serum Institute reduces Covishield price for state govt hospitals

The issue of vaccine pricing has been much debated after the two companies recently put out the prices of their respective vaccines amid the deadly second wave of the pandemic. Opposition has been demanding universal free vaccination.The government had earlier asked the SII and Bharat to lower their prices. The move came ahead of India’s move to expand its drive to include all adults from May 1 under a liberalised and modified vaccination policy.



  1. Pingback: Dr Reddy's launches generic drug in US market | The Plunge Daily

  2. Pingback: Kerala govt caps RT-PCR test price by private labs at Rs 500, down from Rs 1700

  3. Pingback: Here's how much Google saved in a year due to work from home policy

  4. Pingback: No clampdown on citizens seeking medical help on social media: SC warns state, police

  5. Pingback: IIT Bombay pilots new technology that converts nitrogen plant into oxygen generator

  6. Pingback: 'A real life hero': Kannada actor Arjun Gowda turns ambulance driver to help COVID-19 patients

  7. Pingback: Amazon’s earned $ 26.9 billion profit in 2020, more than the last three year's combined

  8. Pingback: Covid-19: Apollo, Max hospitals to start vaccination for 18-44 group from May 1

  9. Pingback: #Funding Alert: Pune startup ElasticRun secures Rs 550 crore for deeper penetration in rural market

Leave a Reply

Your email address will not be published. Required fields are marked *

To Top